Literature DB >> 1577279

Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation.

E Ulrich1, G Boehmelt, A Bird, H Beug.   

Abstract

Clones of mortal chicken fibroblasts and erythroblasts transformed by temperature-sensitive v-src and v-erb B oncoproteins have been developed into immortal cell lines that retain the conditional transformed phenotype. The expressions of two tumor suppressor genes, the retinoblastoma (Rb) gene and the p53 gene, were investigated during senescence, crisis, and cell line establishment. In temperature-sensitive (ts)-v-erb B erythroblasts and ts-v-src fibroblasts (as well as in v-myc macrophages), loss of p53 mRNA or expression of a mutated p53 gene invariably occurred in the early phase of immortalization. In contrast, expression of the Rb gene was unchanged at all stages of immortalization. Inactivation of the original temperature-sensitive oncogene led to loss of the transformed phenotype in fibroblasts and to differentiation in erythroblasts, even in lines that were immortal and lacked p53. The results demonstrate that the process of immortalization is distinct from cell transformation, probably requiring different mutational events.

Entities:  

Mesh:

Year:  1992        PMID: 1577279     DOI: 10.1101/gad.6.5.876

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  18 in total

1.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype.

Authors:  F Mallein-Gerin; B R Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  Evaluating the effects of bioremediation on genotoxicity of polycyclic aromatic hydrocarbon-contaminated soil using genetically engineered, higher eukaryotic cell lines.

Authors:  Jing Hu; Jun Nakamura; Stephen D Richardson; Michael D Aitken
Journal:  Environ Sci Technol       Date:  2012-04-05       Impact factor: 9.028

4.  Deletions in the DNA-binding domain of the TP53 gene in v-src-transformed chicken cells.

Authors:  Katerina Trtková; Jirí Plachý
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

5.  Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras.

Authors:  M Löhr; P Müller; I Zauner; C Schmidt; B Trautmann; F Thévenod; G Capellá; A Farré; S Liebe; R Jesenofsky; R Jesnowski
Journal:  Virchows Arch       Date:  2001-06       Impact factor: 4.064

6.  Convenient, multi-well plate-based DNA damage response analysis using DT40 mutants is applicable to a high-throughput genotoxicity assay with characterization of modes of action.

Authors:  John R Ridpath; Shunichi Takeda; James A Swenberg; Jun Nakamura
Journal:  Environ Mol Mutagen       Date:  2011-03       Impact factor: 3.216

Review 7.  Duplication of the Yeast Spindle Pole Body Once per Cell Cycle.

Authors:  Diana Rüthnick; Elmar Schiebel
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

Review 8.  Centrosomes are multifunctional regulators of genome stability.

Authors:  Dorothy A Lerit; John S Poulton
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

9.  Histone H1 null vertebrate cells exhibit altered nucleosome architecture.

Authors:  Hideharu Hashimoto; Yasunari Takami; Eiichiro Sonoda; Tomohito Iwasaki; Hidetomo Iwano; Makoto Tachibana; Shunichi Takeda; Tatsuo Nakayama; Hiroshi Kimura; Yoichi Shinkai
Journal:  Nucleic Acids Res       Date:  2010-02-15       Impact factor: 16.971

10.  Loss of transformed phenotype upon senescence of Rous sarcoma virus-infected chicken neuroretinal cells.

Authors:  G M Seigel; M F Notter
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.